Dihydrotetrabenazine (DHTBZ) is the active metabolite of Tetrabenazine. Dihydrotetrabenazine is the inhibitor for human vesicular monoamine transporter 2 (VMAT2), that reduces monoamine content in presynaptic neurons, and can be used in movement disorder research[1].